TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ARVN

Arvinas Inc

Healthcare · Biotechnology

8.30$ -0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARVN
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
98.3% 98.0% 98.2% 96.4% 98.0% 98.2% 97.7% 98.1% 97.8% 97.6%
13.4% 46.2% 1.6% 3.1% 82.0% 6.8% 6.4% 23.9% 9.2% 19.9%
93.7% 58.6% 94.3% 93.1% 96.0% 95.0% 95.0% 96.7% 95.2% 95.5%
3.7% 39.0% 2.5% 2.1% 1.2% 1.6% 0.6% 0.6% 1.3% 0.9%
0.0% 0.3% 0.4%
1.7% 1.9% 1.8% 3.6% 1.7% 1.0% 1.1%
36.7% 99.6% 31.4% 24.8% 10.5% 50.6% 55.5% 49.4% 48.5% 39.6%
26.4% 26.7% 11.5% 10.9% 6.9% 16.5% 23.3% 19.7% 21.1% 19.8%
0.4% 0.2% 0.1% 0.2% 0.1% 0.1% 0.1% 0.1% 0.2% 0.2%
4.1% 0.9% 1.4% 1.5% 1.0% 2.0% 0.4% 1.4% 1.2% 3.4%
0.8% 0.2% 1.0% 0.7% 0.3% 0.1% 0.1% 0.1% 0.1% 0.1%
63.3% 0.4% 68.6% 75.2% 89.5% 49.4% 44.5% 50.6% 51.5% 60.4%
-89.1% -93.4% -151.7% -123.5% -68.6% -43.2% -76.1% -102.2% -140.3% -224.6%
47.1% 31.0% 15.9% 10.9% 5.5% 3.2% 4.2% 4.3% 6.6% 9.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?